Brief: Probiotec Says Gross Margins Expected To Reverse Progressively Over Second Half
24/02/2023 01:37
Feb 24 (Reuters) - Probiotec PBP.AX :
* GROSS MARGINS EXPECTED TO REVERSE PROGRESSIVELY OVER
SECOND HALF
OF FY23
* BOARD EXPECTS TO DELIVER SALES OF A$205M TO A$215M FOR
FY23
* BOARD EXPECTS TO DELIVER EBITDA OF A$34.5M TO A$36.0M FOR
FY23
Source text for Eikon: ID:nASXDSQDm
Further company coverage: PBP.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Probiotec
See all newsBrief: ASX Says Probiotec Limited Will Be Removed From The Official List At Close Of Trading On 19 June
Australia's Probiotec hits 4-month high on nod for Pyridam buyout
Brief: Probiotec Says FIRB Condition Satisfied For Proposed Scheme
Australia's Probiotec hits record high on takeover offer
Brief: Probiotec Remains Confident Of Achieving Growth In Sales And Earnings For FY24